V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004911 | 330002367 | 1.58 | 83.7 | Curative (C) | 2016-05-31 | 2016-06-05 | MITOTANE | 02 | N | 330020741 | ECX |
| 330004912 | 330002368 | 177 | 14.9 | Curative (C) | 2014-05-07 | 2014-05-10 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | 330020744 | CARBOPLATIN + RT |
| 330004913 | 330002369 | 1.63 | 56 | Palliative (P) | 2019-04-20 | 2019-05-02 | TEMOZOLOMIDE | N | N | 330020745 | PAZOPANIB |
| 330004915 | 330002371 | 1.77 | 140.6 | Curative (C) | 2017-10-07 | 2017-10-07 | EDP + MITOTANE | 01 | N | 330020757 | AZACITIDINE |
| 330004916 | 330002371 | null | 56.6 | Not known (9) | 2014-03-24 | 2014-03-25 | Abiraterone | N | N | 330020757 | CAPECITABINE + RT |
| 330004917 | 330002372 | 1.52 | 87 | Disease modification (D) | 2015-09-30 | 2015-10-01 | Methotrexate + Folinic acid | Y | N | 330020762 | METHOTREXATE |
| 330004918 | 330002373 | 1.63 | null | Palliative (P) | 2016-03-07 | 2016-03-07 | Cyclophosphamide TBI Allograft | N | null | 330020767 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330004919 | 330002373 | 1.6 | 61.5 | Disease modification (D) | 2014-09-08 | 2014-09-12 | Cytarabine Low Dose | N | N | 330020767 | TEMOZOLOMIDE + RT |
| 330004920 | 330002374 | 1.63 | null | null | 2014-07-05 | 2014-07-21 | Cladribine (subcut) 5 days | N | null | 330020771 | CARBOPLATIN + RT |
| 330004921 | 330002375 | 1.77 | 86 | Palliative (P) | 2013-02-04 | 2013-02-05 | CHOP | 02 | N | 330020774 | BEP |
| 330004922 | 330002376 | 1.59 | 51.1 | null | 2017-04-26 | 2017-04-26 | UKALL XII Induction Phase 1 | Y | N | 330020777 | AZACITIDINE |
| 330004923 | 330002377 | 1.75 | null | Curative (C) | 2013-12-16 | 2013-12-16 | IMATINIB | 02 | N | 330020786 | HYDROXYCARBAMIDE |
| 330004924 | 330002378 | 1.96 | null | Neo-adjuvant (N) | 2013-02-16 | 2013-02-18 | FLAG + Idarubicin | N | N | 330020792 | VINBLASTINE |
| 330004925 | 330002379 | 0 | 11.4 | null | 2015-05-28 | 2015-11-04 | Cytarabine Low Dose | N | N | 330020794 | ICE-R |
| 330004926 | 330002379 | 1.98 | 88.7 | Palliative (P) | 2016-04-08 | 2016-04-22 | BEP 5 Day | N | N | 330020794 | CLADRIBINE |
| 330004927 | 330002379 | 1.31 | 56.6 | Curative (C) | 2013-06-17 | 2013-06-17 | Vinblastine | null | N | 330020794 | AZACITIDINE |
| 330004928 | 330002379 | 1.77 | 64.7 | Palliative (P) | null | 2017-05-01 | Paclitaxel 7 day | null | null | 330020794 | CISPLATIN + FLUOROURACIL + GEMCITABINE |
| 330004929 | 330002380 | 0 | 24.4 | Palliative (P) | 2013-06-10 | 2013-06-11 | Temozolomide + RT | N | null | 330020816 | CISPLATIN + FLUOROURACIL + RT |
| 330004930 | 330002381 | 1.6 | null | Disease modification (D) | 2017-01-14 | 2017-01-15 | Methotrexate intrathecal | 02 | null | 330020818 | CARBOPLATIN + RT |
| 330004931 | 330002381 | 0 | 22.8 | Curative (C) | 2013-12-28 | 2014-01-06 | OST Mifamurtide | N | N | 330020818 | DACARBAZINE |
| 330004932 | 330002381 | null | 68 | Palliative (P) | 2015-10-25 | 2015-10-29 | Hydroxycarbamide | 2 | N | 330020818 | ETOPOSIDE + IFOSFAMIDE + MTX |
| 330004933 | 330002381 | 1.83 | 60.2 | Not known (9) | 2014-12-31 | 2014-12-31 | VINCRISTINE | 01 | N | 330020818 | DOXORUBICIN + IFOSFAMIDE |
| 330004934 | 330002382 | 1.79 | 78.35 | null | 2014-01-14 | 2014-04-20 | Sunitinib | N | N | 330020830 | RUXOLITINIB |
| 330004935 | 330002382 | null | null | Palliative (P) | 2018-04-19 | 2018-04-20 | AML17 TRIAL | null | null | 330020830 | CAV |
| 330004936 | 330009971 | 1.78 | 104.1 | Neo-adjuvant (N) | 2014-05-15 | 2014-05-15 | Azacitidine | N | Y | 330020832 | CARBOPLATIN + PEMETREXED |
| 330004937 | 330002383 | 1.66 | 71 | Curative (C) | 2015-09-15 | 2015-09-18 | Capecitabine (14 days)+Carboplatin | 02 | N | 330020834 | CAPECITABINE + OXALIPLATIN |
| 330004938 | 330002384 | 1.58 | 12.1 | Palliative (P) | 2014-09-01 | 2014-09-01 | VIDE | 2 | N | 330020835 | TEMOZOLOMIDE |
| 330004939 | 330002384 | 1.73 | 85.8 | null | 2015-02-20 | 2015-02-20 | CYTARABINE | N | N | 330020835 | CAPECITABINE + CISPLATIN |
| 330004940 | 330002385 | 0 | 76 | Disease modification (D) | 2015-02-24 | 2015-02-24 | Methotrexate Intrathecal (any age) | 2 | N | 330020845 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330004941 | 330007310 | 0 | 80.6 | null | 2014-10-13 | 2014-10-20 | Doxorubicin + Ifosfamide | 2 | N | 330020849 | CISPLATIN + DOX + ETOPOSIDE |
| 330004942 | 330002386 | 1.8 | 62.5 | Curative (C) | 2013-02-03 | 2013-02-07 | Carboplatin + Doxorubicin | 02 | N | 330020851 | DABRAFENIB |
| 330004943 | 330002386 | 1.6 | null | Disease modification (D) | 2014-04-20 | 2014-04-21 | Mitotane 3 - 3.5g | 02 | N | 330020851 | CAV |
| 330004944 | 330002386 | 1.62 | 86 | Palliative (P) | 2017-08-31 | 2017-09-05 | Dasatinib | N | N | 330020851 | CAV |
| 330004945 | 330002386 | 1.74 | 79 | Palliative (P) | 2016-05-10 | 2016-05-13 | Hydroxycarbamide | N | null | 330020851 | CAV |
| 330004946 | 330002386 | 1.8 | 89.6 | Curative (C) | null | 2017-11-22 | Bendamustine +/- Prednisolone | null | null | 330020851 | AZACITIDINE |
| 330004947 | 330002386 | 1.8 | 60.8 | Curative (C) | 2015-08-23 | 2015-08-29 | BEP 3 day | N | N | 330020851 | CARBOPLATIN + RT |
| 330004948 | 330002386 | 1.65 | null | Palliative (P) | 2014-11-17 | 2014-11-17 | Doxorubicin + Ifosfamide | 02 | N | 330020851 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330004949 | 330002387 | 1.8 | 63 | Disease modification (D) | 2018-09-05 | 2018-09-22 | CARBOPLATIN + VINORELBINE | N | Y | 330020882 | HCX |
| 330004950 | 330002387 | 1.8 | null | null | 2015-08-13 | 2015-09-03 | ECX | N | N | 330020882 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 330004951 | 330002387 | 1.59 | 19.7 | Curative (C) | 2014-09-25 | 2014-09-25 | ALL UKALL2011 Ind B Sht Dex (PAsp) | null | N | 330020882 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004952 | 330002388 | 0.86 | null | Neo-adjuvant (N) | 2013-12-23 | 2013-12-24 | Hydroxycarbamide | Y | N | 330020894 | CARBOPLATIN + DOCETAXEL |
| 330004953 | 330002388 | 1.65 | 54 | Palliative (P) | 2017-06-29 | 2017-07-03 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 330020894 | HYDROXYCARBAMIDE |
| 330004954 | 330002388 | null | null | Curative (C) | 2014-11-25 | 2014-11-25 | AML17 TRIAL | null | null | 330020894 | CARBOPLATIN + VINORELBINE |
| 330004955 | 330002388 | 1.79 | 69.9 | Neo-adjuvant (N) | 2013-12-03 | 2013-12-03 | Capecitabine (14 days)+Carboplatin | Y | N | 330020894 | DOXORUBICIN + IFOSFAMIDE |
| 330004956 | 330002389 | 1.58 | 60.2 | Adjuvant (A) | 2013-10-23 | 2013-10-23 | CHOP - 21 days | N | N | 330020911 | PEMBROLIZUMAB |
| 330004957 | 330002389 | 1.57 | 77.2 | Palliative (P) | 2016-08-10 | 2016-08-31 | Methotrexate + Folinic acid | 02 | N | 330020911 | MIDOSTAURIN |
| 330004958 | 330002390 | 1.83 | 57.9 | Curative (C) | 2014-01-30 | 2014-01-31 | Paclitaxel 7 day | Y | N | 330020923 | BEP |
| 330004959 | 330002390 | 1.63 | 81 | Curative (C) | 2013-02-23 | 2013-03-23 | CARBOPLATIN + RT | N | N | 330020923 | CISPLATIN + FLUOROURACIL + RT |
| 330004960 | 330002390 | 1.71 | 85.8 | Palliative (P) | 2017-04-22 | 2017-05-04 | Cisplatin + Vinorelbine (PO) | 02 | N | 330020923 | BEP |
| 330004961 | 330002391 | null | 11 | Curative (C) | 2013-02-09 | 2013-02-12 | PACLITAXEL | 2 | N | 330020934 | CARBOPLATIN + VINCRISTINE |